Bellco

Fineurop Soditic acted as exclusive financial advisor to Charme II, private equity fund managed by Montezemolo & Partners SGR S.p.A., in the acquisition of a 100% stake in Bellco S.r.l. from Argos Soditic (58%), MPVenture SGR (32%) and the Management (10%) for around Euro 100 million. The transaction has been carried out through a secondary buy out transaction in which Bellco management re-invested in the Company. Established in 1972 near Bologna, the company is among the top worldwide leaders in the haemodialysis medical equipment business. It is a European leading manufacturer and distributors of dialyzers, fluids, machines and hematic lines for the treatment of renal pathologies. Bellco generated 2011 sales of approximately Euro 110 million and an EBITDA of around 17 million. Bellco has 4 direct subsidiaries abroad (Canada, France, Spain and Belgique) and around 54% of its turnover is generated by export. The new investor will sustain Bellco in its international growth as well as market consolidation through new highly-technological and innovative products, fully complying with product and market strategies that have featured the last three years of success.